653 related articles for article (PubMed ID: 24773862)
1. Modification of cardiometabolic profile in obese diabetic patients after bariatric surgery: changes in cardiovascular risk.
Pujante P; Hellín MD; Fornovi A; Martínez Camblor P; Ferrer M; García-Zafra V; Hernández AM; Frutos MD; Luján-Monpeán J; Tébar J
Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):812-8. PubMed ID: 24773862
[TBL] [Abstract][Full Text] [Related]
2. Can bariatric surgery improve cardiovascular risk factors in the metabolically healthy but morbidly obese patient?
Goday A; Benaiges D; Parri A; Ramón JM; Flores-Le Roux JA; Pedro Botet J;
Surg Obes Relat Dis; 2014; 10(5):871-6. PubMed ID: 25282193
[TBL] [Abstract][Full Text] [Related]
3. Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patients.
Sánchez-Pernaute A; Rubio MÁ; Cabrerizo L; Ramos-Levi A; Pérez-Aguirre E; Torres A
Surg Obes Relat Dis; 2015; 11(5):1092-8. PubMed ID: 26048517
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35.
DePaula AL; Macedo AL; Rassi N; Machado CA; Schraibman V; Silva LQ; Halpern A
Surg Endosc; 2008 Mar; 22(3):706-16. PubMed ID: 17704886
[TBL] [Abstract][Full Text] [Related]
5. Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery: A Population-Based Cohort Study in the United Kingdom.
Yska JP; van Roon EN; de Boer A; Leufkens HG; Wilffert B; de Heide LJ; de Vries F; Lalmohamed A
JAMA Surg; 2015 Dec; 150(12):1126-33. PubMed ID: 26422580
[TBL] [Abstract][Full Text] [Related]
6. Metabolic surgery for inadequately controlled type 2 diabetes in nonseverely obese Japanese: a prospective, single-center study.
Seki Y; Kasama K; Yasuda K; Eri Kikkawa ; Watanabe N; Kurokawa Y
Surg Obes Relat Dis; 2018 Jul; 14(7):978-985. PubMed ID: 29724682
[TBL] [Abstract][Full Text] [Related]
7. Midterm impact of sleeve gastrectomy, calibrated with a 50-Fr bougie, on weight loss, glucose homeostasis, lipid profiles, and comorbidities in morbidly obese patients.
Ruiz-Tovar J; Oller I; Tomas A; Llavero C; Arroyo A; Calero A; Martinez-Blasco A; Calpena R
Am Surg; 2012 Sep; 78(9):969-74. PubMed ID: 22964206
[TBL] [Abstract][Full Text] [Related]
8. Reduction of risk factors for cardiovascular diseases in morbid-obese patients following biliary-intestinal bypass: 3 years' follow-up.
Lubrano C; Cornoldi A; Pili M; Falcone S; Brandetti F; Fabbrini E; Ginanni-Corradini S; Eramo A; Marini M; Migliaccio S; Giancotti V; Badiali M; Falsetto N; Prossomariti G; Spera G
Int J Obes Relat Metab Disord; 2004 Dec; 28(12):1600-6. PubMed ID: 15543161
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of body mass index, excess weight loss and body fat percentage trajectories after 3 years of gastric bypass: relationship with metabolic outcomes.
Gómez-Ambrosi J; Andrada P; Valentí V; Rotellar F; Silva C; Catalán V; Rodríguez A; Ramírez B; Moncada R; Escalada J; Salvador J; Frühbeck G
Int J Obes (Lond); 2017 Sep; 41(9):1379-1387. PubMed ID: 28584299
[TBL] [Abstract][Full Text] [Related]
10. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study.
Pontiroli AE; Pizzocri P; Librenti MC; Vedani P; Marchi M; Cucchi E; Orena C; Paganelli M; Giacomelli M; Ferla G; Folli F
J Clin Endocrinol Metab; 2002 Aug; 87(8):3555-61. PubMed ID: 12161474
[TBL] [Abstract][Full Text] [Related]
12. Bariatric surgery reduces risk factors for development of type 2 diabetes mellitus in morbidly obese, nondiabetic patients.
Nestvold TK; Nielsen EW; Lappegård KT
Metab Syndr Relat Disord; 2013 Dec; 11(6):441-6. PubMed ID: 24044780
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome, hypertension, and diabetes mellitus after gastric banding: the role of aging and of duration of obesity.
Pontiroli AE; Alberto M; Paganelli M; Saibene A; Busetto L
Surg Obes Relat Dis; 2013; 9(6):894-900. PubMed ID: 23747312
[TBL] [Abstract][Full Text] [Related]
14. Short-term cardiometabolic risk reduction after bariatric surgery.
Domienik-Karlowicz J; Dzikowska-Diduch O; Lisik W; Chmura A; Pruszczyk P
Hellenic J Cardiol; 2015; 56(1):61-5. PubMed ID: 25701973
[TBL] [Abstract][Full Text] [Related]
15. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass.
Nguyen NT; Varela E; Sabio A; Tran CL; Stamos M; Wilson SE
J Am Coll Surg; 2006 Jul; 203(1):24-9. PubMed ID: 16798484
[TBL] [Abstract][Full Text] [Related]
16. The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity.
Brix JM; Höllerl F; Kopp HP; Schernthaner GH; Schernthaner G
Int J Obes (Lond); 2012 Nov; 36(11):1412-7. PubMed ID: 22828946
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of Bariatric Surgery: Increasing the Economic Viability of the Most Effective Treatment for Type II Diabetes Mellitus.
Warren JA; Ewing JA; Hale AL; Blackhurst DW; Bour ES; Scott JD
Am Surg; 2015 Aug; 81(8):807-11. PubMed ID: 26215244
[TBL] [Abstract][Full Text] [Related]
18. Long-term cardiovascular risk and coronary events in morbidly obese patients treated with laparoscopic gastric banding.
Busetto L; De Stefano F; Pigozzo S; Segato G; De Luca M; Favretti F
Surg Obes Relat Dis; 2014; 10(1):112-20. PubMed ID: 23791451
[TBL] [Abstract][Full Text] [Related]
19. Psoriasis improvement after bariatric surgery.
Romero-Talamás H; Aminian A; Corcelles R; Fernandez AP; Schauer PR; Brethauer S
Surg Obes Relat Dis; 2014; 10(6):1155-9. PubMed ID: 25443045
[TBL] [Abstract][Full Text] [Related]
20. Medium/long term evaluation of lipid profile after bariatric surgery (gastric bypass versus sleeve gastrectomy).
Abellán Garay L; Navarro García MI; González-Costea Martínez R; Torregrosa Pérez NM; Vázquez Rojas JL
Endocrinol Diabetes Nutr (Engl Ed); 2021; 68(6):372-380. PubMed ID: 34742470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
